Press Room
ArtemiC™ Master Supply & Distribution Agreement
Swiss PharmaCan AG signed a Master Supply & Distribution agreement for the exclusive worldwide distribution of ArtemiC™ Rescue
ArtemiC Phase II Clinical Trial Results
MGC Pharmaceuticals, a partner of Swiss PharmaCan, is currently conducting a clinical trial testing the effectiveness and safety of a MyCell Technology™ -based formulation with respect to COVID-19.